I.I.C.H. Intern. Isotopes Clearing · 66-66 · GERMANY
For I.I.C.H. Intern. Isotopes Clearing, import alert is 66-66; country is GERMANY; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Doxorubicin; product code is 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Obergasse 4 , Volxheim, Rhineland-Palatinate GERMANY, verified against its source on 2026-09-30.
- Firm
- I.I.C.H. Intern. Isotopes Clearing verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- GERMANY verified
- Address
- Obergasse 4 , Volxheim, Rhineland-Palatinate GERMANY verified
- Date published
- 09/30/2009 verified
- Product code
- 56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Doxorubicin verified
- FDA notes
- 11/2/2000 verified
What the source says
I.I.C.H. Intern. Isotopes Clearing Date Published : 09/30/2009 Obergasse 4 , Volxheim, Rhineland-Palatinate GERMANY
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
56 H - S 24 Doxorubicin Hydrochloride (Antitumor), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Doxorubicin Notes: 11/2/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html